Five things for pharma marketers to know: Monday, August 1, 2016
1. GlaxoSmithKline formed a joint venture with Verily Life Sciences, which is owned by Google's parent company, to study bioelectronic medicine. The venture, called Galvani Bioelectronics, will focus on developing implants that can change electronic signals passed through nerves in the body. (AP)
2. A few well-known healthcare companies are enhancing their presence in the wearable sensor market. Philips Healthcare launched a set of connected wearable technologies, including a health watch and a blood pressure monitor, while Samsung and and Nestlé announced a collaboration pairing sensor technology and nutrition science.
3. Advent International, a private-equity firm, has taken a stake in inVentiv Health, which had filed for an IPO in April. Its investment values the company at $3.8 billion.
4. The Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization have developed a set of principles aimed at clarifying the status of off-label information in communications with payers and healthcare providers. (Bloomberg BNA)
5. Despite the promise and excitement around immuno-oncology therapies like Merck's Keytruda and Bristol-Myers Squibb's Opdivo, the treatments are only working in a minority of patients. (NYT)